bluuebunny/crossref_metadata_2025_split huggingface dataset:
Acarbose Potentially Binds to the Type I Peptide Deformylase Catalytic Site and
Inhibits Bacterial Growth: An In Silico and In Vitro Study
Authors: Singh Atul Kumar , Prajapati Kumari Sunita , Kumar Shashank 
Published: September 2022

Background:
In bacteria, peptide deformylase (PDF), a metalloenzyme, removes N-formyl methionine from a nascent protein, which is a critical step in the protein maturation process. The enzyme is ubiquitously present in bacteria and possesses therapeutic target potential. Acarbose, an FDA-approved antidiabetic
drug, is an alpha-glucosidase inhibitor of microbial origin. Clinical studies indicate that acarbose administration
in humans can alter gut microbiota. As per the best of our knowledge, the antibacterial potential of acarbose has
not been reported.

Objective:
The present study aimed to check the binding ability of acarbose to the catalytic site of E. coli PDF
and assess its in vitro antibacterial activity.

Methods:
Molecular docking, molecular dynamic (MD) simulation, and MM-PBSA experiments were performed to study the binding potential of the catalytic site, and a disc diffusion assay was also employed to assess the antibacterial potential of acarbose.

Results:
Acarbose was found to form a hydrogen bond and interact with the metal ion present at the catalytic
site. The test compound showed a better docking score in comparison to the standard inhibitor of PDF. MD
simulation results showed energetically stable acarbose-PDF complex formation in terms of RMSD, RMSF,
Rg, SASA, and hydrogen bond formation throughout the simulation period compared to the actinonin-PDF
complex. Furthermore, MM-PBSA calculations showed better binding free energy (∆G) of acarbose PDF than
the actinonin-PDF complex. Moreover, acarbose showed in vitro antibacterial activity.

Conclusion:
Acarbose forms conformational and thermodynamically stable interaction with the E. coli peptide
deformylase catalytic site. Results of the present work necessitate in-depth antimicrobial potential studies on the
effect of acarbose on drug resistance and nonresistant bacteria.
Chia Seeds Oil Suppresses the Resistance of Hepatocellular Carcinoma
Cells to Liposomal-doxorubicin and Upregulates the Tumor Suppressor
miRNAs
Authors: Awad Els T. , Tawfik Shaimaa A. , Abu Bakr Hoda O. , Ahmed Ismail M. , Ashour Esmat , Gamal-Eldeen Amira M. 
Published: September 2022

Background:
Chia seed is an oil-seed of multiple biological activities. Doxorubicin is an effective chemotherapy for liver cancer. Resistance and adverse effects are doxorubicin limitations.

Objective:
This study aimed to investigate the effect of chia seeds oil (CSO) on the resistance of HepG2 cells to liposomal-doxorubicin (DOX).

Methods:
The objective were investigated through measuring cytotoxicity, doxorubicin-metabolizing enzyme Cytochrome P450 3A4 (CYP-3A4), multidrug resistance-associated protein (MRP1), and the expression of multiple tumor suppressor microRNAs.

Results:
The findings indicated that low concentration of CSO increased HepG2 cells sensitivity to DOX as concluded from its higher cytotoxicity. DOX induced mRNAs of CYP-3A4 and MRP1 and their protein levels. CSO inhibited both in DOX-treated cells. CSO induced tumor suppressor miRNAs. Doxorubicin inhibited miR-122 and let-7/b/e expression, while it led to overexpression of let-7a. CSO/DOX upregulated let-7/b/e, miR-34a, and miR-122 (which inhibits MRP1) and downregulated let-7a that may lead to increased apoptosis.

Conclusion:
CSO effectively re-sensitized HepG2 cells to liposomal-doxorubicin via inhibiting MRP1 and CYP-3A4 that may increase in vivo doxorubicin bioavailability and decrease its therapeutic dose to diminish its adverse effects.
Computational Design for Identification of Human Anti-MUC1
Heteroclitic Peptides in the Treatment of HER2-Positive Breast Cancer
through Neural Network Training and Monomeric based Design
Authors: Chhillar Anil Kumar , Behl Akanksha , Das Nagendra Nath , Sharma Krishna Kant , Sharma Namita , Gulia Prity 
Published: September 2022

Aims:
Generation of human anti-MUC1 peptide through neural network training and monomeric design method. Analyzing 9-mer peptide potential computationally for treatment of HER2-positive breast cancer.

Background:
Extract human MUC1 sequences from various databases. 2. Perform neural networking method for novel peptides sequences. Analyze the potentiality of generated heteroclitic peptide sequences for suitable vaccine candidate for breast cancer treatment.

Objective:
Monomeric based design option was selected for evolutionary and physics based simulations of human anti MUC1. Neural network training, evolutionary profiling, MHC interaction values revealed two anti-MUC1 heteroclitic peptide epitopes which can induce cytotoxic T-lymphocyte response to invade tumour cells.  Alignment-independent prediction of subunit vaccine potency and allergenicity nature suggested putative anti MUC1 heteroclitic peptides.  A 9-mer in silico designed heteroclitic peptide WAVWTYVSV indicated promising values which can be utilised as tumour marker or drug delivery candidate in the treatment of human breast cancer.

Method:
Input Scaffolds of protein data base (PDB) files for human MUC1 were retrieved and loaded into Evo design server with monomeric based design option. Further, neural network training approaches were followed and other computational tools were used for alignment-independent prediction of protective antigens and subunit vaccines potency of designed heteroclitic peptides.

Result:
Study findings revealed two human anti-MUC1 heteroclitic peptides of 9mers (WAVWTYVSV, FMSFYIMNL) which showed lowest energy cluster and sequence identity (Fig. 1 and Fig. 3), normalized relative error rate of secondary structure, solvent accessibility, backbone torsion angles for neural networking (Fig. 2 and Fig. 4) and RMSD values in evolutionary profiling, online MHCPred IC50 interaction values (supplementary file-1, supplementary file-2). VaxiGen v2.0 server revealed subunit vaccine potency values of in-silico designed two heteroclitic peptides were as 0.1551 (WAVWTYVSV), 0.3508 (FMSFYIMNL) with threshold value of 0.5 followed by AllerTOP v2.0 for their allergenicity nature in immunogenic reactions (supplementary file-1, supplementary file-2).

Conclusion:
Computationally designed heteroclitic peptide WAVWTYVSV indicated promising values which can be utilised as drug delivery or tumour marker candidate in the treatment of human breast cancer by eliciting lyse of tumor cells.
Positive Expression of Paired Box 5 (Pax5) was Associated with Age,
Tumor Location, and Tumor Size of Patients with Gastrointestinal Neuroendocrine
Tumors (NETs)
Authors: Zhang Ting , Hong Fangfang , Wu Haibo 
Published: September 2022

Background:
Neuroendocrine tumors (NETs) can occur in most human epithelial organs,
however, there are few studies on digestive system NETs.

Aims:
The study aims to analyze Pax5 expression in digestive tract NETs and discuss its diagnostic significance.

Methods:
This study included 64 cases of NETs diagnosed from 2019 to 2020. Expressions of paired box
5 (Pax5), CD56, synaptophysin (Syn), and chromogranin (CgA) were detected using the immunohistochemical
assay. Clinicopathological parameters, including tumor location, histological classification,
depth of infiltration, tumor diameter, lymph node metastasis, vascular tumor thrombus, and nerve invasion,
were determined in Pax5 positive and negative patients. Spearman correlation analysis was performed
to analyze the correlation between Pax5 and CD56, Syn, and CgA.

Results:
The positive rate of Pax5 expression in patients with NETs was 46.9% (30/64). There were more
patients ≥60 years illustrating positive expression of Pax5 compared to those patients <60 years
(χ2=8.438, P=0.004). There were significant differences in histological classification between Pax5 positive
expression patients and Pax5 negative expression patients (χ2=17.639, P=0.011). Significant Pax5
positive expression patients demonstrated tumor size ≥3 cm, compared to Pax5 negative expression patients
(χ2=6.764, P=0.009). Therefore, positive Pax5 expression was related to age, histological classification,
and tumor size of NETs patients. Pax5 expression in digestive system NETs was not correlated with
CD56 (χ2=0.233, r=0.024, P=0.853), Syn (χ2=0.635, r=0.047, P=0.715), CgA (χ2=2.346, r=0.170,
P=0.179).

Conclusions:
Positive expression of Pax5 was related to age, tumor location, and tumor size of NETs patients.
Pax5 can be used in combination with common immune markers (CD56/Syn/CgA) and can improve
the diagnostic accuracy of digestive system NETs.
Effect of Mesioangular Impaction of the Mandibular Third Molars on the
Adjacent Mandibular Second Molars: An Imaging Study
Authors: Liu Liuhui , Zhang Limin , Lu Sijin , Huang Wukai , Song Liang , Xu Bin 
Published: September 2022

Objective:
To investigate the effect of mesioangular impaction of the mandibular third molars
on distal caries and distal bone loss (DBL) in the adjacent mandibular second molars to provide a
basis for prophylactic impacted third molar extraction.

Methods:
We retrospectively analyzed panoramic radiographs of 736 patients with mesioangularly
impacted mandibular third molars at the Department of Stomatology, Shanghai Fifth People’s Hospital.
The chi-square test, the Kruskal-Wallis test, and logistic regression were performed to analyze the
relationship of patient age, sex, mesial inclination angle, distal caries, and DBL in the mandibular second
molars.

Results:
Patient aged over 30 years and a mesial inclination angle > 30° were risk factors for distal
caries in the mandibular second molars (p < 0.05). Patients aged over 20 years and a mesial inclination
angle of 60°-90° were risk factors for DBL (p < 0.05).

Conclusion:
In patients with mesioangularly impacted mandibular third molars, age and the mesial
inclination angle were positively correlated with the severity of distal caries and DBL in the adjacent
mandibular second molars. These findings could guide dental practitioners to prevent complications of
the adjacent molars during early prophylactic extraction of the mandibular third molars with mesioangular
inclination.
Developing Female Students’ Motor Skills and Improving Basketball Playing Techniques by Means of Special Exercise Machines
Authors: Tymoshenko Oleksii , Domina Zhanna , Malechko Tetiana , Nesterova Tatiana , Korkh-Cherba Oksana , Redkina Maria , Konovalska Liudmyla , Poluliashchenko Tetiana , Soltyk Oleksandr , Shkilna Iryna , Prontenko Kostiantyn , Bloshchynskyi Ihor 
Published: September 2022

Introduction:
The article presents the technology of using technical equipment to develop the accuracy of ballistic movements, spatial-dynamic sensitivity during ballthrows and rebounds, as well as speed and strength qualities to improve jumping movements, implementation of fast breakthroughs, strong and long passes in basketball.

Methods:
The research involved 96 female students aged 17-23 years forming the experimental (EG, n = 54) and control (CG, n = 42) groups. The female students of EG played basketball in the conditions of group physical education training sessions using the exercise machines developed by us, and the female students of the CG were engaged in basketball playing according to the traditional program without the use of developed exercise machines and had an initial level of basketball technique. The EG was divided into EG1 (n = 37) and EG2 (n = 17) subgroups, which included female students having initial and high levels of basketball technique mastery, respectively. Female basketball players with an initial level of training (EG1 and СG) had experience of up to 3 years, athletes with a high level of training (EG2) - playing experience of more than 10 years. The technology of technical equipment application in basketball is built on the basis of the use of designed portable exercise machines to implement the tasks of motor and technical training of female basketball players of different levels of training.

Results
The results of the conducted experiment showed that the accuracy of throws from the average distance increased by 40.9% and 29.4% in the EG1 and EG2 female students, and it grew by 9.9% in the CG; from the long distance – by 61.5%, 37.0% and 31.3% respectively; the level of development of speed and strength qualities of female students of all groups improved i. e. the rate of growth in the results of the long jump made 9.7%, 3.2% and 6.5%, respectively; the rate of growth in the results of the high jump made 20.0%, 6.3% and 8.7%, respectively.

Conclusion:
Experimental testing of the technology of using designed exercise machines for the development of motor skills of female basketball students confirmed its effectiveness in terms of improving the spatial and dynamic accuracy of movement, speed and strength, as well as game performance of basketball players at competitions of various levels.
Where Do I Start? A Pathway for Personal Growth for Faculty Committed to Creating Inclusive Classrooms
Authors: Bishop-Monroe Robbie , Garcia Joanna L. 
Published: September 2022

ABSTRACT
This commentary offers insights into how accounting faculty can begin to create more inclusive, equitable experiences for students. Many faculty are well intentioned and desire to improve the student experience but may not know where to start. We introduce a pathway of reflection, education, and action that we believe can help faculty get started on this process. Reflection is the process of assessing one’s own identity, influences, biases, and personal experiences with diversity and privilege. Education involves seeking out information and experiences that can enhance cultural competence, particularly around gaps identified through reflection. Action refers to practical steps taken to make classrooms more inclusive, including classroom management and curricular changes. We draw upon professional experiences in academia and personal knowledge as authors with diverse racial and ethnic backgrounds to guide faculty interested in beginning to develop more inclusive classrooms.
Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis
Authors: Poirrier Jean-Etienne , Meyers Juliana L. , Nagar Saurabh P. , Patterson Brandon J. , Glasser Lisa I. , Jabbour Serge A. 
Published: September 2022

OBJECTIVE
Data on the real-world burden of herpes zoster (HZ) in adults with type 2 diabetes (T2D) in the U.S. are limited. We assessed HZ in patients with and without T2D and measured the impact of HZ on health care resource use (HCRU) and costs.

RESEARCH DESIGN AND METHODS
This retrospective cohort analysis used U.S. commercial claims data (sourced from claims incurred between 1 January 2012 and 31 July 2018). HZ incidence rates/1,000 person-years (PYs) were calculated in patients with and without T2D. HZ risk was evaluated using Poisson regression to generate adjusted incidence rate ratios (aIRRs). Patients with T2D with HZ were propensity score matched to patients with T2D only and to patients with HZ without T2D. HCRU and costs were compared across cohorts during a 1-year follow-up period. Cox proportional hazards analyses evaluated factors associated with HZ-related complications.

RESULTS
Crude HZ incidence rates in patients with and without T2D were 9.8/1,000 PY and 2.6/1,000 PY, respectively. T2D patients were almost twice as likely to be diagnosed with HZ (aIRR 1.84; 95% CI 1.82–1.85). HZ was associated with increased HCRU and health care costs. At 12 months, unadjusted incremental all-cause health care costs for patients with T2D with HZ versus patients with T2D without HZ were $5,216. The unadjusted incremental HZ-related health care costs for patients with T2D with HZ versus patients with HZ without T2D were $2,726. Age was the most important predictor for HZ-related complications.

CONCLUSIONS
Given the increased risk of HZ and HCRU and cost burden in patients with T2D, HZ prevention in patients with T2D may be beneficial.
Systematic review and network meta-analysis of neurostimulation for painful diabetic neuropathy
Authors: Duarte Rui V. , Nevitt Sarah , Copley Sue , Maden Michelle , Vos Cecile C de , Taylor Rod S , Eldabe Sam 
Published: September 2022

<p> </p>
<p><strong>Background: </strong>Different waveforms of spinal cord stimulation (SCS) have now been evaluated for the management of painful diabetic neuropathy (PDN). However, no direct or indirect comparison between SCS waveforms has been performed to date.</p>
<p><strong>Purpose:</strong> To conduct a systematic review and network meta-analysis (NMA) to evaluate the effectiveness of SCS for PDN.</p>
<p><strong>Data sources:</strong> MEDLINE, CENTRAL, Embase and WikiStim were searched from inception until December 2021.</p>
<p><strong>Study selection:</strong> Randomised controlled trials (RCTs) of SCS for PDN were included.</p>
<p><strong>Data extraction:</strong> Pain intensity, proportion of patients achieving at least a 50% reduction in pain intensity and health-related quality-of-life (HRQoL) data were extracted.</p>
<p><strong>Data synthesis:</strong> Significant reductions in pain intensity were observed for low-frequency SCS (LF-SCS) (mean difference [MD] -3.13, 95% confidence interval [CI] -4.19 to -2.08, moderate certainty) and high-frequency SCS (HF-SCS) (MD -5.20, 95% CI -5.77 to -4.63, moderate certainty) compared to conventional medical management (CMM) alone. There was a significantly greater reduction in pain intensity on HF-SCS compared to LF-SCS (MD -2.07, 95% CI -3.26 to -0.87, moderate certainty). Significant differences were observed for LF-SCS and HF-SCS compared to CMM for the outcomes proportion of patients with at least 50% pain reduction and HRQoL (very low to moderate certainty). No significant differences were observed between LF-SCS and HF-SCS (very low to moderate certainty).</p>
<p>Limitations: Limited number of RCTs and no head-to-head RCTs conducted.</p>
<p><strong>Conclusions:</strong> Our findings confirm the pain relief and HRQoL benefits of the addition of SCS to CMM for patients with PDN. However, in the absence of head-to-head RCT evidence the relative benefits of HF-SCS compared to LF-SCS for patients with PDN remains uncertain.</p>
<p><br></p>
Risk of reoperation due to surgical site infection in 74,771 hip fracture patients: a Danish nationwide cohort study
Authors: Kristensen Nicolai K , Lange Jeppe , Frøslev Trine , Pedersen Alma B 
Published: September 2022

Background and purpose: Surgical site infection (SSI) after hip fracture surgery is a feared condition. We examined the trend in incidence of reoperation due to SSI up to 1 year following hip fracture surgery from 2005 to 2016 and risk factors of SSI by age, sex, comorbidity, type of fracture, and surgery.Patients and methods: We conducted a population-based, nationwide cohort study using data from the Danish Multidisciplinary Hip Fracture Register (DMHFR). We included 74,771 patients aged 65 and up who underwent surgery from 2005 to 2016 for all types of hip fracture. We calculated net risk of reoperation using Kaplan–Meier method, and, with Cox regression, adjusted hazard ratios (HRs) with a 95% confidence interval (CI) for reoperation due to SSI.Results: Overall, the 1-year net risk of reoperation due to SSI was 1.6%. The HR was higher for patients undergoing total/hemiarthroplasty surgery versus internal fixation (HR = 1.5; 95%CI 1.3–1.8) and lower for patients with per-/subtrochanteric fracture versus femoral neck fracture (HR = 0.6; CI 0.6–0.7). The risk of reoperation due to SSI decreased over time; HR was 0.7 (CI 0.5–0.8) for 2015–2016 compared with 2005–2006. Risk of reoperation decreased with increasing age; the HR was 0.8 (CI 0.7–1.0) in the more than 85-year-olds compared with 65–74-year-old patients. Charlson Comorbidity Index of ≥ 3 was associated with a higher risk of reoperation due to SSI, HR was 1.3 (CI 1.1–1.6).Interpretation: The net risk of reoperations due to SSI in our study was lower than previously assumed. We identified several risk factors for increased risk of reoperation due to SSI, most noticeably treatment with arthroplasty vs. internal fixation, as well as younger age, high comorbidity burden, and femoral neck fracture diagnosis.
This is version 2 of this manuscript with all corrections included, see Corrigendum, doi: 10.2340/17453674.2022.5357
Consumer Enforcement Opportunities – New Approaches and Trends in Hungarian Procedural Laws
Authors: Gombos Katalin , Pomeisl András J. 
Published: September 2022

Summary
The European Union has put in place EU rules on consumer contracts and enforcement of consumer rights. These tendencies have also had a significant impact on the Hungarian legislation of recent years. We would describe some provisions of the new Hungarian Code of Civil Procedure concerning consumer enforcement and the Hungarian experience of Directive 93/13/EEC so far. The new Hungarian Code of Civil Procedure has reformed domestic rules on jurisdiction in the field of a consumer’s claim arising from a contractual relationship. The article also covers the following areas of law: Hungarian experience with foreign currency-based loan agreements, reforms to the preliminary ruling procedure in the new Hungarian Code of Civil Procedure.
Resolution of Cases for Consumer Protection under Civil Procedure in Poland. Selected Issues
Authors: Drozdowicz Krzysztof 
Published: September 2022

Summary
The article addresses selected issues related to the resolution of cases for consumer protection under civil procedure in Poland. Although consumer law is mainly the domain of substantive civil law, in civil procedural law there are also normative solutions concerning this issue and they will be discussed in the article. The author will present new legal instruments aimed at increasing the effectiveness of consumer protection in civil proceedings, as well as the proposed changes that should be under debate.
Crosstalk between adipose tissue and the heart: An update
Authors: Li Chao , Sun Xue-Nan , Zhao Shangang , Scherer Philipp E. 
Published: September 2022

Abstract
It is important to understand how different human organs coordinate and interact with each other. Since obesity and cardiac disease frequently coincide, the crosstalk between adipose tissues and heart has drawn attention. We appreciate that specific peptides/proteins, lipids, nucleic acids, and even organelles shuttle between the adipose tissues and heart. These bioactive components can profoundly affect the metabolism of cells in distal organs, including heart. Importantly, this process can be dysregulated under pathophysiological conditions. This also opens the door to efforts targeting these mediators as potential therapeutic strategies to treat patients who manifest diabetes and cardiovascular disease. Here, we summarize the recent progress toward a better understanding of how the adipose tissues and heart interact with each other.